annb0t
Top 20
MELBOURNE, Australia, Jan. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)Â today advises it is presenting at the 41st Annual J.P. Morgan Healthcare Conference (9 â 12 January) in San Francisco.
As part of the Company's presentation (available to view or download from the investor page of the Telix corporate website here), Telix has elected to disclose an unaudited revenue update for Q4 2022, reporting revenue of AU$76.8M (US$50.5M) generated from sal...
>>> Read more: Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
As part of the Company's presentation (available to view or download from the investor page of the Telix corporate website here), Telix has elected to disclose an unaudited revenue update for Q4 2022, reporting revenue of AU$76.8M (US$50.5M) generated from sal...
>>> Read more: Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
